Shelton Capital Management Abiomed Inc Transaction History

Shelton Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$278.07 - $446.21 $749,954 - $1.2 Million	-2,697 Closed	0 $0
Q3 2017 Nov 28, 2017	BUY	$145.39 - $168.6 $392,116 - $454,714	2,697 New	2,697 $455,000
Q3 2017 Nov 14, 2017	SELL	$145.39 - $168.6 $392,116 - $454,714	-2,697 Closed	0 $0
Q1 2017 Nov 28, 2017	SELL	N/A	-3,273 Reduced 54.82%	2,697 $338,000
Q3 2016 Dec 04, 2017	BUY	N/A	5,970	5,970 $673,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.